HIV Citation List: February 1 - February 14, 2013

PubMed citations

1. Emtricitabine Prodrugs with Improved anti-HIV Activity and Cellular Uptake. Agarwal, H.K., B.S. Chhikara, S. Bhavaraju, D. Mandal, G.F. Doncel, and K. Parang. Molecular Pharmaceutics, 2013. 10(2): p. 467-476. PMID[22917277].
[PubMed]. HIV_0201-021413.

2. Comparison of the Molecular Dynamics and Calculated Binding Free Energies for Nine FDA-approved HIV-1 PR Drugs against Subtype B and C-SA HIV PR. Ahmed, S.M., H.G. Kruger, T. Govender, G.E. Maguire, Y. Sayed, M.A. Ibrahim, P. Naicker, and M.E. Soliman. Chemical Biology & Drug Design, 2013. 81(2): p. 208-218. PMID[23017010].
[PubMed]. HIV_0201-021413.

3. GRL-0519, a Novel Oxatricyclic-ligand-containing Nonpeptidic HIV-1 Protease Inhibitor (PI), Potently Suppresses the Replication of a Wide Spectrum of Multi-PI-resistant HIV-1 Variants in Vitro. Amano, M., Y. Tojo, P.M. Salcedo-Gomez, J.R. Campbell, D. Das, M. Aoki, C.X. Xu, K.V. Rao, A.K. Ghosh, and H. Mitsuya. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23403426].
[PubMed]. HIV_0201-021413.

4. Covalent Fusion Inhibitors Targeting HIV-1 gp41 Deep Pocket. Bai, Y., H. Xue, K. Wang, L. Cai, J. Qiu, S. Bi, L. Lai, M. Cheng, S. Liu, and K. Liu. Amino Acids, 2013. 44(2): p. 701-713. PMID[22961335].
[PubMed]. HIV_0201-021413.

5. A Rationally Engineered anti-HIV Peptide Fusion Inhibitor with Greatly Reduced Immunogenicity. Brauer, F., K. Schmidt, R.C. Zahn, C. Richter, H.H. Radeke, J.E. Schmitz, D. von Laer, and L. Egerer. Antimicrobial Agents and Chemotherapy, 2013. 57(2): p. 679-688. PMID[23147734].
[PubMed]. HIV_0201-021413.

6. New Betulinic Acid Derivatives for Bevirimat-resistant Human Immunodeficiency Virus Type-1. Dang, Z., P. Ho, L. Zhu, K. Qian, K.H. Lee, L. Huang, and C.H. Chen. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23379607].
[PubMed]. HIV_0201-021413.

7. Antiviral Activity of Retrocyclin RC-101, a Candidate Microbicide against Cell-associated HIV-1. Gupta, P., C. Lackman-Smith, B. Snyder, D. Ratner, L.C. Rohan, D. Patton, B. Ramratnam, and A.M. Cole. Aids Research and Human Retroviruses, 2013. 29(2): p. 391-396. PMID[22924614].
[PubMed]. HIV_0201-021413.

8. Efficient Single Tobamoviral Vector-based Bioproduction of Broadly Neutralizing anti-HIV-1 Monoclonal Antibody VRC01 in Nicotiana Plants and Its Utility in Combination Microbicides. Hamorsky, K.T., T.W. Grooms-Williams, A.S. Husk, L.J. Bennett, K.E. Palmer, and N. Matoba. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23403432].
[PubMed]. HIV_0201-021413.

9. Antiviral Phenolic Compounds from Arundina gramnifolia. Hu, Q.F., B. Zhou, J.M. Huang, X.M. Gao, L.D. Shu, G.Y. Yang, and C.T. Che. Journal of Natural Products, 2013. [Epub ahead of print]. PMID[23368966].
[PubMed]. HIV_0201-021413.

10. Design, Synthesis and Biological Evaluation of Indolizine Derivatives as HIV-1 VIF-ElonginC Interaction Inhibitors. Huang, W., T. Zuo, H. Jin, Z. Liu, Z. Yang, X. Yu, L. Zhang, and L. Zhang. Molecular Diversity, 2013. [Epub ahead of print]. PMID[23378232].
[PubMed]. HIV_0201-021413.

11. Non-natural Peptide Triazole Antagonists of HIV-1 Envelope gp120. Kamanna, K., R. Aneja, C. Duffy, P. Kubinski, D. Rodrigo Moreira, L.D. Bailey, K. McFadden, A. Schon, A. Holmes, F. Tuzer, M. Contarino, E. Freire, and I.M. Chaiken. ChemMedChem, 2013. 8(2): p. 322-328. PMID[23239505].
[PubMed]. HIV_0201-021413.

12. CXCR4-tropic, but Not CCR5-tropic, Human Immunodeficiency Virus Infection Is Inhibited by the Lipid Raft-associated Factors, Acyclic Retinoid Analogs, and Cholera Toxin B Subunit. Kamiyama, H., K. Kakoki, S. Shigematsu, M. Izumida, Y. Yashima, Y. Tanaka, H. Hayashi, T. Matsuyama, H. Sato, N. Yamamoto, T. Sano, Y. Shidoji, and Y. Kubo. Aids Research and Human Retroviruses, 2013. 29(2): p. 279-288. PMID[22845664].
[PubMed]. HIV_0201-021413.

13. Biological Profile of the Less Lipophilic and Synthetically More Accessible Bryostatin 7 Closely Resembles That of Bryostatin 1. Kedei, N., N.E. Lewin, T. Geczy, J. Selezneva, D.C. Braun, J. Chen, M.A. Herrmann, M.R. Heldman, L. Lim, P. Mannan, S.H. Garfield, Y.B. Poudel, T.J. Cummins, A. Rudra, P.M. Blumberg, and G.E. Keck. ACS Chemical Biology, 2013. [Epub ahead of print]. PMID[23369356].
[PubMed]. HIV_0201-021413.

14. Inhibition of HIV-1 Replication by a Tricyclic Coumarin GUT-70 in Acutely and Chronically Infected Cells. Kudo, E., M. Taura, K. Matsuda, M. Shimamoto, R. Kariya, H. Goto, S. Hattori, S. Kimura, and S. Okada. Bioorganic & Medicinal Chemistry Letters, 2013. 23(3): p. 606-609. PMID[23290051].
[PubMed]. HIV_0201-021413.

15. Effect of Combination Antiretroviral Therapy on Chinese Rhesus Macaques of SIV Infection. Ling, B., L.B. Rogers, A.M. Johnson, M. Piatak, J. Lifson, and R. Veazey. Aids Research and Human Retroviruses, 2013. [Epub ahead of print]. PMID[23387294].
[PubMed]. HIV_0201-021413.

16. Trimeric Glycosylphosphatidylinositol-anchored HCDR3 of Broadly Neutralizing Antibody PG16 Is a Potent HIV-1 Entry Inhibitor. Liu, L., W. Wang, L. Yang, H. Ren, J.T. Kimata, and P. Zhou. Journal of Virology, 2013. 87(3): p. 1899-1905. PMID[23152526].
[PubMed]. HIV_0201-021413.

17. Purification and Characterization of a Novel Antifungal Protein with Antiproliferation and anti-HIV-1 Reverse Transcriptase Activities from Peganum harmala Seeds. Ma, X., D. Liu, H. Tang, Y. Wang, T. Wu, Y. Li, J. Yang, J. Yang, S. Sun, and F. Zhang. Acta Biochimica et Biophysica Sinica, 2013. 45(2): p. 87-94. PMID[23165744].
[PubMed]. HIV_0201-021413.

18. Complete and Repeatable Inactivation of HIV-1 Viral Particles in Suspension Using a Photo-labeled Non-nucleoside Reverse Transcriptase Inhibitor. Marin-Muller, C., A. Rios, D. Anderson, E. Siwak, and Q. Yao. Journal of Virological Methods, 2013. [Epub ahead of print]. PMID[23384676].
[PubMed]. HIV_0201-021413.

19. Synthesis and HIV-1 RT Inhibitory Action of Novel (4/6-substituted Benzo[d]thiazol -2-yl)thiazolidin-4-ones. Divergence from the Non-competitive Inhibition Mechanism. Pitta, E., A. Geronikaki, S. Surmava, P. Eleftheriou, V.P. Mehta, and E.V. Van der Eycken. Journal of Enzyme Inhibition and Medicinal Chemistry, 2013. 28(1): p. 113-122. PMID[22380777].
[PubMed]. HIV_0201-021413.

20. In Vitro Investigations into the Roles of Drug Transporters and Metabolizing Enzymes in the Disposition and Drug Interactions of Dolutegravir, a HIV Integrase Inhibitor. Reese, M.J., P.M. Savina, G.T. Generaux, H. Tracey, J.E. Humphreys, E. Kanaoka, L.O. Webster, K.A. Harmon, J.D. Clarke, and J.W. Polli. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 2013. 41(2): p. 353-361. PMID[23132334].
[PubMed]. HIV_0201-021413.

21. Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment 13. Synthesis and Profiling of a Novel Amminium Prodrug of the HIV-1 Attachment Inhibitor BMS-585248. Regueiro-Ren, A., J. Simmermacher-Mayer, M. Sinz, K.A. Johnson, X.S. Huang, S. Jenkins, D. Parker, S. Rahematpura, M. Zheng, N.A. Meanwell, and J.F. Kadow. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23374053].
[PubMed]. HIV_0201-021413.

22. Some Hydrazones of 2-Aroylamino-3-methylbutanohydrazide: Synthesis, Molecular Modeling Studies, and Identification as Stereoselective Inhibitors of HIV-1. Tatar, E., I. Kucukguzel, D. Daelemans, T.T. Talele, N. Kaushik-Basu, E. De Clercq, and C. Pannecouque. Archiv der Pharmazie, 2013. 346(2): p. 140-153. PMID[23280502].
[PubMed]. HIV_0201-021413.

23. HIV-1 ENV gp120 Structural Determinants for Peptide Triazole Dual Receptor Site Antagonism. Tuzer, F., N. Madani, K. Kamanna, I. Zentner, J. Lalonde, A. Holmes, E. Upton, S. Rajagopal, K. McFadden, M. Contarino, J. Sodroski, and I. Chaiken. Proteins, 2013. 81(2): p. 271-290. PMID[23011758].
[PubMed]. HIV_0201-021413.

24. Potent Inhibition of HIV-1 Reverse Transcriptase and Replication by Nonpseudoknot, "UCAA-motif" RNA Aptamers. Whatley, A.S., M.A. Ditzler, M.J. Lange, E. Biondi, A.W. Sawyer, J.L. Chang, J.D. Franken, and D.H. Burke. Molecular Therapy. Nucleic Acids, 2013. 2: p. e71. PMID[23385524].
[PubMed]. HIV_0201-021413.

25. In Vitro Analysis and Quantitative Prediction of Efavirenz Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effects on CYPs 2B6, 2C8, 2C9 and 2C19. Xu, C. and Z. Desta. Drug Metabolism and Pharmacokinetics, 2013. [Epub ahead of print]. PMID[23385314].
[PubMed]. HIV_0201-021413.

26. Antiviral Peptide Nanocomplexes as a Potential Therapeutic Modality for HIV/HCV Co-infection. Zhang, J., A. Mulvenon, E. Makarov, J. Wagoner, J. Knibbe, J.O. Kim, N. Osna, T.K. Bronich, and L.Y. Poluektova. Biomaterials, 2013. [Epub ahead of print]. PMID[23403120].
[PubMed]. HIV_0201-021413.

ISI Web of Knowledge Citations

27. 1,2,4-Triazine Chemistry Part III: Synthetic Strategies to Functionalized Bridgehead Nitrogen Heteroannulated 1,2,4-Triazine Systems and Their Regiospecific and Pharmacological Properties. Abdel-Rahman, R.M., M.S.T. Makki, T.E. Ali, and M.A. Ibrahim. Current Organic Synthesis, 2013. 10(1): p. 136-160. ISI[000313065200006].
[WOS]. HIV_0201-021413.

28. Analysis of Small Molecule Ligands Targeting the HIV-1 Matrix protein-RNA Binding Site. Alfadhli, A., H. McNett, J. Eccles, S. Tsagli, C. Noviello, R. Sloan, C.S. Lopez, D.H. Peyton, and E. Barklis. Journal of Biological Chemistry, 2013. 288(1): p. 666-676. ISI[000313197200067].
[WOS]. HIV_0201-021413.

29. Positional Adaptability in the Design of Mutation-resistant Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors: A Supramolecular Perspective. Bruccoleri, A. Aids Research and Human Retroviruses, 2013. 29(1): p. 4-12. ISI[000313036800002].
[WOS]. HIV_0201-021413.

30. Anti-HIV-1 Activity of Elafin Depends on Its Nuclear Localization and Altered Innate Immune Activation in Female Genital Epithelial Cells. Drannik, A.G., K. Nag, X.D. Yao, B.M. Henrick, T.B. Ball, F.A. Plummer, C. Wachihi, J. Kimani, and K.L. Rosenthal. Plos One, 2012. 7(12). ISI[000312829100075].
[WOS]. HIV_0201-021413.

31. Amniotic Fluid Exhibits an Innate Inhibitory Activity against HIV Type 1 Replication in Vitro. Farzin, A., P. Boyer, B. Ank, K. Nielsen-Saines, and Y. Bryson. Aids Research and Human Retroviruses, 2013. 29(1): p. 77-83. ISI[000313036800013].
[WOS]. HIV_0201-021413.

32. Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design. Frey, K.M., M. Bollini, A.C. Mislak, J.A. Cisneros, R. Gallardo-Macias, W.L. Jorgensen, and K.S. Anderson. Journal of the American Chemical Society, 2012. 134(48): p. 19501-19503. ISI[000311869600001].
[WOS]. HIV_0201-021413.

33. Inhibitors of HIV-1 Integrase-human LEDGF/p75 Interaction Identified from Natural Products Via Virtual Screening. Hu, G.P., X. Li, Y.Z. Li, X.Q. Sun, G.X. Liu, W.H. Li, J. Huang, X. Shen, and Y. Tang. Chinese Journal of Chemistry, 2012. 30(12): p. 2752-2758. ISI[000312942500006].
[WOS]. HIV_0201-021413.

34. Synthesis and Conformation of Novel 4 '-Fluorinated 5 '-deoxythreosyl phosphonic acid Nucleosides as Antiviral Agents. Kang, L., E. Kim, E.J. Choi, J.C. Yoo, W. Lee, and J.H. Hong. Bulletin of the Korean Chemical Society, 2012. 33(12): p. 4007-4014. ISI[000313154400018].
[WOS]. HIV_0201-021413.

35. Isolation and Biological Activities of Furanoflavones from the Roots of Codonopsis cordifolioidea. Leng, H.Q., G.Y. Yang, Y.K. Chen, Y.D. Guo, and Z.Y. Chen. Asian Journal of Chemistry, 2013. 25(4): p. 2024-2026. ISI[000312621500057].
[WOS]. HIV_0201-021413.

36. A One-pot Transition-metal-free Tandem Process to 1,4-Benzodiazepine Scaffolds. Li, Y.Q., C.J. Zhan, B.C. Yang, X.Q. Cao, and C. Ma. Synthesis-Stuttgart, 2013. 45(1): p. 111-117. ISI[000313322900014].
[WOS]. HIV_0201-021413.

37. Phenolic Compounds from Clinopodium urticifolium and Their Antivirus Activities. Pan, C., J. Huang, Z.R. Gao, W. Feng, G.Y. Yang, Y.G. Chen, and Z. Li. Asian Journal of Chemistry, 2013. 25(4): p. 1860-1862. ISI[000312621500023].
[WOS]. HIV_0201-021413.

38. Microwave Assisted, One Pot Synthesis of Alkyl-3-amino-2-arylimino-1,3-thiazolan-4-ones-5-ylidene acetate. Pourshamsian, K., N. Montazeri, S. Ahamadi, and T. Noghani. Asian Journal of Chemistry, 2013. 25(1): p. 306-308. ISI[000312620300059].
[WOS]. HIV_0201-021413.

39. Benzophenone Derivatives of Pyrimidines as Effective Non-nucleoside Inhibitors of Wild-type and Drug-resistant HIV-1 Reverse Transcriptase. Prokofjeva, M.M., V.T. Valuev-Elliston, A.V. Ivanov, S.N. Kochetkov, M.S. Novikov, and V.S. Prassolov. Doklady Biochemistry and Biophysics, 2012. 447(1): p. 280-281. ISI[000313071500004].
[WOS]. HIV_0201-021413.

40. HRP2 Determines the Efficiency and Specificity of HIV-1 Integration in LEDGF/p75 Knockout Cells but Does Not Contribute to the Antiviral Activity of a Potent LEDGF/p75-binding Site Integrase Inhibitor. Wang, H., K.A. Jurado, X.L. Wu, M.C. Shun, X. Li, A.L. Ferris, S.J. Smith, P.A. Patel, J.R. Fuchs, P. Cherepanov, M. Kvaratskhelia, S.H. Hughes, and A. Engelman. Nucleic Acids Research, 2012. 40(22): p. 11518-11530. ISI[000313414800036].
[WOS]. HIV_0201-021413.

Patent Citations

41. The Effect of Graphene Oxide on Conformation Change, Aggregation and Cytotoxicity of HIV-1 Regulatory Protein (Vpr). Zhang, M., X.B. Mao, C.X. Wang, W.F. Zeng, C.L. Zhang, Z.J. Li, Y. Fang, Y.L. Yang, W. Liang, and C. Wang. Biomaterials, 2013. 34(4): p. 1383-1390. ISI[000313155800051].
[WOS]. HIV_0201-021413.

42. Preparation of Amino acid Amides as Antiviral Agents. Chen, P., D. Zhou, S. Shao, and Z.-W. Cai. Patent. 2013. 2012-US45761 2013006792: 92pp.

[Patent]. HIV_0201-021413.

43. Preparation of Azaindole Compounds and Methods for Treating HIV. de La Rosa, M.A., B.A. Johns, E.J. Velthuisen, J. Weatherhead, and V. Samano. Patent. 2013. 2012-547199 20130018049: 167pp.

[Patent]. HIV_0201-021413.

44. Processes for Preparing C-3 Substituted Bicyclooctane Based HIV Protease Inhibitors. Ghosh, A.K., B.D. Chapsal, and H. Mitsuya. Patent. 2013. 2012-US46216 2013009844: 62pp.

[Patent]. HIV_0201-021413.

45. Preparation of Pyridinones and Related Compounds as HIV Replication Inhibitors. Hattori, K., N. Kurihara, T. Iwaki, T. Inoue, T. Akiyama, and Y. Hasegawa. Patent. 2013. 2012-JP66642 2013002357: 367pp.

[Patent]. HIV_0201-021413.